Orthofix announces executive leadership changes
Click Here to Manage Email Alerts
Key takeaways:
- Orthofix announced Massimo Calafiore as president and CEO and Julie Andrews as chief financial officer.
- Calafiore will also serve on the board of directors.
- Calafiore succeeds interim CEO Catherine Burzik.
Orthofix Medical Inc. has announced Massimo Calafiore as president and CEO and Julie Andrews as chief financial officer, according to a company press release.
Calafiore, who will also serve on the board of directors for Orthofix, has previously held leadership roles with LimaCorporate S.pA. and NuVasive. He assumes the roles of president and CEO of Orthofix, effective immediately.
“I am honored to officially begin this role at this important time for the company, and I am excited to welcome Julie to the team next week,” Calafiore said in the release. “I look forward to working with the more than 1,600 employees who dedicate themselves to furthering our mission to deliver meaningful and life-improving technologies for our surgeon customers and their patients,” Calafiore said.
Andrews most recently served as chief financial officer of Smart Wires Technology. She also held roles at Wright Medical Group and Medtronic. She will assume the role of chief financial officer of Orthofix, effective Jan. 15.
“Our search for these critical management roles was executed quickly and thoroughly, with many highly qualified candidates expressing interest in leading Orthofix,” Catherine Burzik, chair of the board of directors and former interim CEO of Orthofix, said in the release. “We are confident we have chosen two visionary executives who will bring meaningful perspectives and expertise to the company and that their leadership will serve us well in the years ahead,” she added.